25-58248 - Professional services - GMP Production Documentation and Technical Support consultant for Clinical Trial Material Facility (CTMF). (Канада - Тендер #71459712) | ||
| ||
| Для перевода текста тендера на нужный язык воспользуйтесь приложением: | ||
Страна: Канада (другие тендеры и закупки Канада) Организатор тендера: www.merx.com Номер конкурса: 71459712 Дата публикации: 23-03-2026 Источник тендера: www.merx.com |
||
cb-793-15476481
Issuing OrganizationNational Research Council of Canada (NRC)
Solicitation TypeRFP - Request for Proposal (Formal)
Solicitation Number25-58248
TitleProfessional services - GMP Production Documentation and Technical Support consultant for Clinical Trial Material Facility (CTMF).
Source IDPWGSC
Agreement TypesCanada-Chile Free Trade Agreement (CCFTA)
Canada-Colombia Free Trade Agreement
Canada-European Union Comprehensive Economic and Trade Agreement(CETA)
Canada-Honduras Free Trade Agreement
Canada-Korea Free Trade Agreement
Canada-Panama Free Trade Agreement
Canada-Peru Free Trade Agreement (CPFTA)
Canadian Free Trade Agreement (CFTA)
Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP)
World Trade Organization Agreement on Government Procurement (WTO-AGP)
Canada-UK Trade Continuity Agreement (Canada-UK TCA)
Canada-Ukraine Free Trade Agreement (CUFTA)
Canada
2026/03/22 12:00:00 AM EDT
Closing Date2026/04/15 02:00:00 PM EDT
Cindy Romain
(613) 299-2748
cindy.romain@nrc-cnrc.gc.ca
Good Manufacturing Practices (GMP) consultant support to generate, review and approve
production documentation (i.e. SOPs, logbooks, validation protocol IQ/OQ/PQ and reports,
validation test scripts, study, deviation, CAPA, risk assessment, material code specification,
change control). In addition, the consultant will act as a technical advisor to the production
manager.
This is a contract to support the production manager on the review of all related
documentation for Data Integrity Assessment and Validation PQs. These activities are required
to ensure that production can move forward with the CTMF projects for bulk drug product
manufacturing beginning in April 2026.